X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1039) 1039
Patent (62) 62
Newspaper Article (57) 57
Book Chapter (28) 28
Book Review (13) 13
Publication (10) 10
Book / eBook (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (504) 504
female (303) 303
male (295) 295
cardiac & cardiovascular systems (234) 234
middle aged (233) 233
aged (217) 217
mortality (202) 202
clinical trials (165) 165
risk factors (153) 153
abridged index medicus (149) 149
treatment outcome (139) 139
medicine, general & internal (122) 122
adult (101) 101
heart attacks (99) 99
patients (94) 94
prospective studies (92) 92
heart failure (91) 91
cardiovascular (89) 89
internal medicine (87) 87
analysis (84) 84
care and treatment (80) 80
drug therapy (79) 79
acute coronary syndromes (76) 76
follow-up studies (76) 76
medical research (75) 75
risk (71) 71
time factors (70) 70
myocardial infarction (69) 69
cardiovascular disease (66) 66
research (64) 64
stroke (64) 64
studies (64) 64
outcomes (63) 63
aged, 80 and over (62) 62
diabetes (62) 62
percutaneous coronary intervention (62) 62
hygiene (61) 61
devices for introducing media into, or onto, the body (59) 59
devices for producing or ending sleep or stupor (59) 59
devices for transducing body media or for taking media fromthe body (59) 59
human necessities (59) 59
medical or veterinary science (59) 59
prognosis (59) 59
randomized controlled trials as topic (59) 59
cardiac patients (56) 56
patient outcomes (56) 56
coronary heart disease (55) 55
transluminal angioplasty (54) 54
cardiovascular diseases (53) 53
epidemiology (53) 53
cohort studies (51) 51
intervention (50) 50
myocardial-infarction (50) 50
blood pressure (49) 49
cardiology (49) 49
research design (49) 49
risk assessment (49) 49
stents (49) 49
health aspects (48) 48
angioplasty (47) 47
double-blind method (47) 47
hypertension (46) 46
public, environmental & occupational health (46) 46
surgery (46) 46
therapy (46) 46
cardiology and cardiovascular medicine (45) 45
confidence intervals (45) 45
drug therapy, combination (45) 45
prevention (44) 44
clopidogrel (42) 42
hospitalization (42) 42
proportional hazards models (41) 41
survival (41) 41
data interpretation, statistical (40) 40
management (40) 40
medicine (40) 40
medicine, experimental (40) 40
usage (40) 40
disease (39) 39
peripheral vascular disease (39) 39
animals (38) 38
cardiac and cardiovascular systems (38) 38
heart failure - mortality (38) 38
kardiologi (38) 38
medicine, research & experimental (38) 38
bleeding (37) 37
coronary vessels (37) 37
morbidity (37) 37
kaplan-meier estimate (36) 36
thrombosis (36) 36
coronary artery bypass (35) 35
metaanalysis (35) 35
trial (35) 35
association (34) 34
acute coronary syndrome (33) 33
endocrinology & metabolism (33) 33
statistical analysis (33) 33
statistics (33) 33
statistics & probability (33) 33
clinical medicine (32) 32
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 1, pp. 11 - 21
...Related Article: Editorial, N Engl J Med 2011 ;364 :11 -80 Members of the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure... 
SURVIVAL | TRIAL | LEFT-VENTRICULAR DYSFUNCTION | TASK-FORCE | SPIRONOLACTONE | ACUTE MYOCARDIAL-INFARCTION | ALDOSTERONE | CARDIAC FIBROSIS | ASSOCIATION | UMCG Approved | MINERALOCORTICOID RECEPTOR | MEDICINE, GENERAL & INTERNAL | ACTIVATION | MYOCARDIAL-INFARCTION | COLLABORATION | CANDESARTAN | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Hospitalization - statistics & numerical data | Mineralocorticoid Receptor Antagonists - adverse effects | Male | Combined Modality Therapy | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Cardiovascular Agents - therapeutic use | Heart Failure - classification | Defibrillators, Implantable | Cardiovascular Diseases - mortality | Female | Aged | Spironolactone - analogs & derivatives | Spironolactone - therapeutic use | Spironolactone - adverse effects | Heart Failure - mortality | Heart failure | Diagnosis | Drug therapy | Risk factors | Hospitalization | Heart attacks | Statistical analysis | Cardiovascular Diseases/mortality | Cardiovascular Agents/therapeutic use | Aldosterone Antagonists/adverse effects/therapeutic use | Implantable | Kardiologi | Heart Failure/classification/drug therapy/mortality | Cardiac and Cardiovascular Systems | Spironolactone/adverse effects/analogs & derivatives/therapeutic use | Defibrillators | Hospitalization/statistics & numerical data
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 18, pp. 1695 - 1705
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 23, pp. 2187 - 2198
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2012, Volume 308, Issue 24, pp. 2594 - 2604
The CONSORT (Consolidated Standards of Reporting Trials) Statement, which includes a checklist and a flow diagram, is a guideline developed to help authors... 
ISSUES | EXPLANATION | ACTIVE-W | MEDICINE, GENERAL & INTERNAL | MULTICENTER | QUALITY | CLINICAL-TRIALS | DOUBLE-BLIND | PREVENTION | CANCER | NON-INFERIORITY TRIALS | Data Interpretation, Statistical | Sample Size | Endpoint Determination | Checklist | Treatment Outcome | Research Design | Quality Control | Randomized Controlled Trials as Topic | Clinical trials
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 9, pp. 861 - 870
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9681, pp. 2125 - 2135
Journal Article